Dr. Steven Isakoff, MD, PhD
Claim this profileMassachusetts General Hospital Cancer Center
Studies Breast Cancer
Studies Breast cancer
7 reported clinical trials
13 drugs studied
Area of expertise
1Breast Cancer
Stage IV
HER2 negative
PR negative
2Breast Cancer
Stage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Steven Isakoff, MD, PhD is currently running
Onvansertib + Paclitaxel
for Breast Cancer
This trial is testing the safety and effectiveness of combining Onvansertib, an experimental drug, with Paclitaxel, a chemotherapy drug, in patients with advanced triple-negative breast cancer. The goal is to find the best dose of Onvansertib and see if this combination can help treat this aggressive form of cancer.
Recruiting1 award Phase 1 & 211 criteria
Radiation + Immunotherapy + PARP Inhibitor
for Breast Cancer
This research study is looking to see whether the combination of Dostarlimab and Niraparib plus Radiation Therapy (RT) is safe and effective in participants with metastatic triple negative breast cancer. The names of the study treatment involved in this study are: * Dostarlimab * Niraparib * Radiation Therapy (RT), which is given per standard of care.
Recruiting1 award Phase 215 criteria
More about Steven Isakoff, MD, PhD
Clinical Trial Related7 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Steven Isakoff, MD, PhD has experience with
- Dostarlimab
- Niraparib
- Pembrolizumab
- PVX-410
- DBT-TOBI
- Durvalumab
Breakdown of trials Steven Isakoff, MD, PhD has run
Breast Cancer
Breast cancer
Skin Cancer
BRCA2 Mutation
BRCA1 Mutation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Steven Isakoff, MD, PhD specialize in?
Steven Isakoff, MD, PhD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Steven Isakoff, MD, PhD currently recruiting for clinical trials?
Yes, Steven Isakoff, MD, PhD is currently recruiting for 3 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Steven Isakoff, MD, PhD has studied deeply?
Yes, Steven Isakoff, MD, PhD has studied treatments such as Dostarlimab, Niraparib, Pembrolizumab.
What is the best way to schedule an appointment with Steven Isakoff, MD, PhD?
Apply for one of the trials that Steven Isakoff, MD, PhD is conducting.
What is the office address of Steven Isakoff, MD, PhD?
The office of Steven Isakoff, MD, PhD is located at: Massachusetts General Hospital Cancer Center, Boston, Massachusetts 02215 United States. This is the address for their practice at the Massachusetts General Hospital Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.